Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]

NCT04149743 is registered in ClinicalTrials.gov with Aventusoft, LLC. as lead sponsor.

NCT NCT04149743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04149743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]
Lead sponsor
Aventusoft, LLC.
Phase
Not applicable
Overall status
Recruiting
Start date
January 31, 2022
Completion date
December 31, 2024
Enrollment
420 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure (hf)